tiprankstipranks
Advertisement
Advertisement

CRIS Stock Latest News

Curis Regains Nasdaq Compliance, Faces One-Year Monitoring
Company AnnouncementsCuris Regains Nasdaq Compliance, Faces One-Year Monitoring
3d ago
8K
CRIS
Curis doses first five patients in TakeAim CLL study
PremiumThe Fly
Curis doses first five patients in TakeAim CLL study
3d ago
CRIS
Is CRIS a Buy, Before Earnings?
PremiumPre-Earnings
Is CRIS a Buy, Before Earnings?
5d ago
CRIS
Curis price target raised to $43 from $17 at H.C. Wainwright
PremiumThe Fly
Curis price target raised to $43 from $17 at H.C. Wainwright
9d ago
CRIS
Curis to report clinical data in the TakeAim Lymphoma study
PremiumThe Fly
Curis to report clinical data in the TakeAim Lymphoma study
11d ago
CRIS
Curis consents first six patients in TakeAim CLL study
PremiumThe FlyCuris consents first six patients in TakeAim CLL study
27d ago
CRIS
Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (July 6 to July 10) – Stay Invested
28d ago
JZ
SVC
Curis trading halted, news pending
Premium
The Fly
Curis trading halted, news pending
1M ago
CRIS
Curis Implements 1-for-20 Reverse Stock Split
PremiumCompany Announcements
Curis Implements 1-for-20 Reverse Stock Split
1M ago
8K
CRIS
Curis Stockholders Approve 1-for-20 Reverse Split
PremiumCompany Announcements
Curis Stockholders Approve 1-for-20 Reverse Split
1M ago
8K
CRIS
Analyst Reiterates Buy on Curis, Maintains $17 Price Target Amid Progress in TakeAim CLL Trial and Nasdaq Compliance Steps
PremiumRatings
Analyst Reiterates Buy on Curis, Maintains $17 Price Target Amid Progress in TakeAim CLL Trial and Nasdaq Compliance Steps
1M ago
CRIS
Curis announces eleven active clinical sites in TakeAim CLL study
PremiumThe Fly
Curis announces eleven active clinical sites in TakeAim CLL study
1M ago
CRIS
Curis Shareholders Approve Flexible Reverse Stock Split Authorization
PremiumCompany AnnouncementsCuris Shareholders Approve Flexible Reverse Stock Split Authorization
1M ago
8K
CRIS
Curis Shareholders Approve Expanded Capital Structure and Governance
Premium
Company Announcements
Curis Shareholders Approve Expanded Capital Structure and Governance
2M ago
8K
CRIS
Why Is Vanguard Total Stock Market (VTI) ETF Falling Today, 5/15/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Falling Today, 5/15/26?
3M ago
VTI
AAPL
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/14/26?
PremiumMarket News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/14/26?
3M ago
VTI
AAPL
Curis Inc. Earnings Call Highlights Clinical Momentum
PremiumCompany Announcements
Curis Inc. Earnings Call Highlights Clinical Momentum
3M ago
CRIS
Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/13/26?
PremiumMarket News
Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/13/26?
3M ago
AGL
VTI
Curis Reaffirmed at Buy as Analyst Maintains $5 Price Target on Emavusertib Clinical Catalysts in CLL and PCNSL
PremiumRatings
Curis Reaffirmed at Buy as Analyst Maintains $5 Price Target on Emavusertib Clinical Catalysts in CLL and PCNSL
3M ago
CRIS
Curis Buy Rating Reiterated as Analyst Highlights Dual-Blockade Progress and Clinical Catalysts; $17 Price Target Maintained
PremiumRatingsCuris Buy Rating Reiterated as Analyst Highlights Dual-Blockade Progress and Clinical Catalysts; $17 Price Target Maintained
3M ago
CRIS
Curis reports Q1 EPS ($1.25), consensus (29c)
Premium
The Fly
Curis reports Q1 EPS ($1.25), consensus (29c)
3M ago
CRIS
Curis sees cash and proceeds enough for operations into second half of FY27
Premium
The Fly
Curis sees cash and proceeds enough for operations into second half of FY27
3M ago
CRIS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >